Related Experiment Videos
Unusual infections in diabetes
1Diabetes Centre, Royal Hallamshire Hospital, Sheffield, UK. mdp95smr@sheffield.ac.uk
Diabetes Research and Clinical Practice
|May 23, 1998
Summary
People with diabetes are prone to rare infections like necrotizing fasciitis and Fournier's gangrene. Prompt recognition and intensive treatment, including antibiotics and surgery, are crucial to reduce high morbidity and mortality rates in these patients.
Area of Science:
- Infectious Diseases
- Endocrinology
- Surgical Pathology
Background:
- Diabetes mellitus is associated with an increased susceptibility to infections.
- Infections in diabetic patients, especially those caused by rare organisms or at unusual sites, pose significant clinical challenges.
- Delayed diagnosis and treatment of these infections can lead to severe complications and increased mortality.
Observation:
- This report details several cases of severe infections in diabetic individuals, including necrotizing fasciitis, malignant otitis externa, Fournier's gangrene, and psoas abscess.
- These conditions required intensive management involving antibiotics, surgical debridement, and glycemic control with insulin.
- The observed infections highlight the potential for aggressive and unusual presentations in the diabetic population.
Findings:
- Diabetic patients present with a higher frequency of infections involving rare organisms or occurring at unusual anatomical locations.
- Necrotizing fasciitis, malignant otitis externa, Fournier's gangrene, and psoas abscess are among the severe infections observed.
- Effective management necessitates a multi-modal approach, combining antimicrobial therapy, surgical intervention, and meticulous insulin therapy.
Implications:
- Early recognition and prompt, aggressive treatment are critical for improving outcomes in diabetic patients with severe infections.
- Impaired cellular defense mechanisms in diabetes may contribute to the increased risk and severity of these infections.
- Further research into the immunological deficits in diabetes could lead to improved preventative strategies and therapeutic interventions.